Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Key Ratios

NASDAQLPCN
Price & Volume
Recent Price$4.71
52 Week High$11.79
52 Week Low$2.38
Average Volume (30 days)25.88K
Beta1.19
Share Related Items
Market Cap$25.19M
Shares Outstanding5.35M
Float5.02M
Dividend Information
Yield %--
Annual Dividend--
Payout Ratio-32.3%
Financial Strength
Quick Ratio (MRQ)12.6
Current Ratio (MRQ)13.0
LT Debt/Capital (MRQ)0%
Total Debt/Equity (MRQ)0%
Valuation Ratios
Price/Earnings (TTM)--
Price/Sales (TTM)3.21
Price/Book (MRQ)1.33
Price/Cash Flow (TTM)(2.30)
Per Share Data
Earnings (TTM)($1.86)
Sales (TTM)($0.53)
Book Value (MRQ)$3.57
Cash Flow (TTM)($0.92)
Cash (MRQ)$3.71
Management Effectiveness
Return on Equity (TTM)-19.5%
Return on Assets (TTM)-17.9%
Return on Investment (TTM)-10.0%
Profitability
Gross Margin (TTM)131.8%
EBIT Margin (TTM)-26.2%
Profit Margin (TTM)-51.2%